Clinical Trial Update: Study of Two Marketed Ocular Anti-Allergy Medications in Subjects With Allergic Conjunctivitis [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating two marketed ocular anti-allergy medications in subjects with allergic conjunctivitis; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Conjunctivitis

Drugs mentioned

• Marketed ocular anti-allergy medication 1
• Marketed ocular anti-allergy medication 2

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Allergic Conjunctivitis | Phase 4 | Status: COMPLETED | Results posted: 2009-05-27